The University of Queensland Diamantina Institute's researchers have played a leading role in a recent study into osteoporosis, more than doubling the number of currently known genes in the disease. In their study published in the leading genetic journal Nature Genetics, variants in 56 regions of the genome have been discovered to influence the bone mineral density (BMD) of individuals
30 April, 2012
A common cancer drug and a drug used for a rare condition affecting the heart could together treat an aggressive form of lung cancer called non-small cell lung cancer (NSCLC), according to a study published in Cell.
26 April, 2012
Molecular modeling is the theme of this month’s issue of Drug Discovery Today’s Editor’s Choice newsletter. Molecular modeling is an established computational toolbox to assist early drug discovery and development. It can be used to generate ideas on a compounds or macromolecules 3D conformation, protein–ligand interactions, and to make predictions on biological activities. In close collaboration with medicinal chemistry and biological experiments, the incorporation of molecular modeling can bring helpful insights into the behavior of molecules and make early drug discovery more efficient.
26 April, 2012
The United States Supreme Court this week handed down another decision affecting patent law in biotechnology. The case decided this week will have an immediate impact on the makers of generic and branded pharmaceuticals.
24 April, 2012
ew research carried out by a University of Dundee scientist could lead to new uses for one of the world’s oldest medicines.
20 April, 2012
The FDA has approved Avid Radiopharmaceuticals’ (now part of Eli Lilly) Amyvid which is a brain plaque diagnostic tool using florbetapir (F-AV-45). This radiotracer dye agent is delivered intravenously and is drawn to beta-amyloid, thus allowing a physician to see accumulations of amyloid in the brain.
17 April, 2012
BioCity Scotland, the centre for life science businesses in Newhouse, Lanarkshire, will award a prize worth £10,000 at this year’s BioEntrepreneur Boot Camp Scotland, a three-day intensive business development programme designed to prepare scientists to be their own boss.
02 April, 2012
The latest issue of Drug Discovery Today is packed full of industry focused research articles, new developments in drug discovery, and expert comment and opinion.
02 April, 2012